Characterization of MCF-12A cell phenotype, response to estrogens, and growth in 3D

[1]  S. Horbach,et al.  The ghosts of HeLa: How cell line misidentification contaminates the scientific literature , 2017, PloS one.

[2]  Maël Montévil,et al.  Modeling mammary organogenesis from biological first principles: Cells and their physical constraints. , 2016, Progress in biophysics and molecular biology.

[3]  Maël Montévil,et al.  SAMA: A Method for 3D Morphological Analysis , 2016, PloS one.

[4]  J. Vadgama,et al.  Long-term exposure of MCF-12A normal human breast epithelial cells to ethanol induces epithelial mesenchymal transition and oncogenic features , 2016, International journal of oncology.

[5]  K. Eliceiri,et al.  Dense Collagen-I Matrices Enhance Pro-Tumorigenic Estrogen-Prolactin Crosstalk in MCF-7 and T47D Breast Cancer Cells , 2015, PloS one.

[6]  C. Stephen Downes,et al.  From Single Cells to Tissues: Interactions between the Matrix and Human Breast Cells in Real Time , 2014, PloS one.

[7]  L. Ellisen,et al.  Basal cell signaling by p63 controls luminal progenitor function and lactation via NRG1. , 2014, Developmental cell.

[8]  C. Sonnenschein,et al.  Breast epithelial tissue morphology is affected in 3D cultures by species-specific collagen-based extracellular matrix. , 2012, Journal of biomedical materials research. Part A.

[9]  S. Marchese,et al.  Disruption of 3D MCF-12A Breast Cell Cultures by Estrogens – An In Vitro Model for ER-Mediated Changes Indicative of Hormonal Carcinogenesis , 2012, PloS one.

[10]  Ana M Soto,et al.  Dual regulation of breast tubulogenesis using extracellular matrix composition and stromal cells. , 2012, Tissue engineering. Part A.

[11]  A. Joubert,et al.  In vitro effects of an in silico‐modelled 17β‐estradiol derivative in combination with dichloroacetic acid on MCF‐7 and MCF‐12A cells , 2011, Cell proliferation.

[12]  V. Ganapathy,et al.  SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer. , 2011, Cancer research.

[13]  U. Kragl,et al.  Proliferative effects of five traditional Nigerian medicinal plant extracts on human breast and bone cancer cell lines. , 2011, Journal of ethnopharmacology.

[14]  Jing Wu,et al.  Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer. , 2011, Cancer letters.

[15]  J. Bussink,et al.  Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  P. Blackshear,et al.  The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes , 2010, Oncogene.

[17]  Ana M Soto,et al.  The microenvironment determines the breast cancer cells' phenotype: organization of MCF7 cells in 3D cultures , 2010, BMC Cancer.

[18]  R. Goldman,et al.  Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  Carlos Sonnenschein,et al.  The role of collagen reorganization on mammary epithelial morphogenesis in a 3D culture model. , 2010, Biomaterials.

[20]  M. Hung,et al.  The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines , 2010, Breast cancer : basic and clinical research.

[21]  S. Hilsenbeck,et al.  Cyclopamine inhibition of human breast cancer cell growth independent of Smoothened (Smo) , 2009, Breast Cancer Research and Treatment.

[22]  Ana M Soto,et al.  A novel 3D in vitro culture model to study stromal-epithelial interactions in the mammary gland. , 2008, Tissue engineering. Part C, Methods.

[23]  F. Al-Khodairy,et al.  Cytotoxic and genotoxic potentials of newly synthesized antiviral aminopyrazoloquinoline derivatives , 2008, Medicinal Chemistry Research.

[24]  M. Bosland,et al.  Roles of hormone replacement therapy and iron in proliferation of breast epithelial cells with different estrogen and progesterone receptor status. , 2008, Breast.

[25]  Jayanta Debnath,et al.  Modeling morphogenesis and oncogenesis in three-dimensional breast epithelial cultures. , 2008, Annual review of pathology.

[26]  Genee Y. Lee,et al.  The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression , 2007, Molecular oncology.

[27]  A. Ashworth,et al.  Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland , 2007, The Journal of cell biology.

[28]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[29]  Kanyawim Kirtikara,et al.  Sulforhodamine B colorimetric assay for cytotoxicity screening , 2006, Nature Protocols.

[30]  G. Tzanakakis,et al.  Effects of the natural isoflavonoid genistein on growth, signaling pathways and gene expression of matrix macromolecules by breast cancer cells. , 2006, Mini reviews in medicinal chemistry.

[31]  Meenakshi Singh,et al.  Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis. , 2006, The American journal of pathology.

[32]  M. Omary,et al.  Cellular integrity plus: organelle-related and protein-targeting functions of intermediate filaments. , 2005, Trends in cell biology.

[33]  Cynthia A. Reinhart-King,et al.  Tensional homeostasis and the malignant phenotype. , 2005, Cancer cell.

[34]  P. Schedin,et al.  Mammary ECM composition and function are altered by reproductive state , 2004, Molecular carcinogenesis.

[35]  A. Theocharis,et al.  Expression of MMPs and TIMPs genes in human breast cancer epithelial cells depends on cell culture conditions and is associated with their invasive potential. , 2004, Anticancer research.

[36]  J. Tentler,et al.  ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells , 2004, Oncogene.

[37]  M. Lacroix,et al.  Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update , 2004, Breast Cancer Research and Treatment.

[38]  K. Coser,et al.  Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Kletsas,et al.  Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP‐2 and MMP‐9) by human epithelial breast cancer cells , 2003, International journal of cancer.

[40]  Valerie Speirs,et al.  Breast cancer cell lines: friend or foe? , 2003, Breast Cancer Research.

[41]  H. Brown,et al.  Selective estrogen receptor (ER) modulators differentially regulate phospholipase D catalytic activity in ER-negative breast cancer cells. , 2002, Molecular pharmacology.

[42]  R Montironi,et al.  p63 is a prostate basal cell marker and is required for prostate development. , 2000, The American journal of pathology.

[43]  Christopher P. Crum,et al.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development , 1999, Nature.

[44]  Carlos Sonnenschein,et al.  Human serum albumin shares the properties of estrocolyone-I, the inhibitor of the proliferation of estrogen-target cells , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[45]  M. Noguchi,et al.  Clinical significance of E-cadherin and vimentin co-expression in breast cancer. , 1996, International journal of oncology.

[46]  C Sonnenschein,et al.  The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. , 1995, Environmental health perspectives.

[47]  N. Olea,et al.  The E-screen assay: a comparison of different MCF7 cell stocks. , 1995, Environmental health perspectives.

[48]  C. Sonnenschein,et al.  A plasma-borne specific inhibitor of the proliferation of human estrogen-sensitive breast tumor cells (estrocolyone-I) , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[49]  H. Soule,et al.  Characterization of epithelial phenotypes in mortal and immortal human breast cells , 1992, International journal of cancer.

[50]  C Sonnenschein,et al.  The role of estrogens on the proliferation of human breast tumor cells (MCF-7). , 1985, Journal of steroid biochemistry.

[51]  Irene Georgakoudi,et al.  Hormonal regulation of epithelial organization in a three-dimensional breast tissue culture model. , 2014, Tissue engineering. Part C, Methods.

[52]  R. Zeillinger,et al.  Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines , 2005, Breast Cancer Research and Treatment.

[53]  C. Osborne,et al.  Biological differences among MCF-7 human breast cancer cell lines from different laboratories , 2005, Breast Cancer Research and Treatment.